Jeuveau (prabotulinumtoxinA-xvfs) and Botox (onabotulinumtoxinA) are both FDA-approved neuromodulators for the temporary improvement of moderate to severe glabellar lines. While their mechanisms are similar, recent clinical research highlights distinct differences in...
It’s one of the most common beauty frustrations: you look in the mirror and see tired, shadowed eyes—no matter how much you sleep. But what’s actually causing that worn-out look? Is it true “dark circles,” or are under-eye hollows to blame? Understanding the...
Think you know everything about Botox? Misinformation is everywhere—fueling fear, confusion, and missed opportunities for safe, natural-looking rejuvenation. Let’s cut through the noise with real science, expert insight, and the clinical experience of Dr. Sherly...
Facial wrinkles are not all the same—understanding the difference between dynamic and static wrinkles is critical for selecting the most effective, evidence-based non-surgical treatments. Scientific advances now allow for precise targeting of each wrinkle type,...
IV therapy and vitamin injections deliver nutrients directly into the bloodstream, bypassing the digestive system for rapid absorption. These treatments are used for specific medical indications such as nutrient deficiencies, malabsorption, and recovery from illness...
Acquired ptosis, or drooping of the upper eyelid, affects millions of adults and can impair both vision and appearance. Oxymetazoline 0.1% ophthalmic solution (Upneeq®) is the first FDA-approved, non-surgical therapy for acquired blepharoptosis in adults, offering...
Bimatoprost ophthalmic solution 0.03% (Latisse®) is the only FDA-approved prescription treatment for eyelash hypotrichosis, clinically proven to enhance eyelash length, thickness, and darkness through stimulation of the hair growth cycle. Since its approval in 2008...
Polidocanol, marketed as Asclera® in the United States, is an FDA-approved sclerosing agent used for the nonsurgical treatment of spider veins and reticular veins. Its efficacy and safety are supported by extensive clinical research, positioning it as a leading option...
GLP-1 and GIP agonist injectables, including semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound™), have transformed evidence-based medical weight loss, achieving up to 20% body weight reduction in clinical trials. Rapid weight loss can lead to...
Platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and exosomes represent the forefront of regenerative injectables, offering cell-based and cell-free options for tissue repair, wound healing, and aesthetic rejuvenation. These therapies leverage autologous or...
